Loading...
Partners 2017-10-02T17:27:58+00:00

Partners

Redbiotec focuses on patients needs only. We therefore actively evaluate partnerning opportunities with the ultimate goal to reinforce our products and/or to add value to therapies of our collaboration partners.

Selected customers and collaboration partners

Further undisclosed big pharma und biotech partners.

Selected technology partners

Redbiotec offers the following partnering opportunities

  • Collaborations on projects upon customer’s demand based on Redbiotec’s know-how and technology
  • Collaborations in the field of HSV2
  • Collaborations in the field of oncolytic viruses and cancer immunotherapies

Please contact us to discuss collaboration opportunities.

 

Scientific Collaborations

BIA Separations

With the support from BIA Separations, Redbiotec has been screening different monoliths as newmatrices for its chromatographic steps during the downstream processing of our VLPs.

ETH Zurich

Redbiotec hold an exclusive license for co-expression technologies of the ETH Zurich.

GE Healthcare

Redbiotec has a scientific collaboration with GE Healthcare for testing hollow fibers used in the recovery and purification of VLPs.

University of Freiburg

Redbiotec has entered a collaboration with its scientific advisor, Prof. Wilfried Weber, University of Freiburg, to explore further applications of Redbiotec’s rePAX® technology in the field of synthetic biology.

ZHAW (Zurich University of Applied Sciences)

Redbiotec has a longstanding collaboration with the team of Prof. Dr. Ing. Regine Eibl, leader in cell cultivation technique, for the development of state-of-the-art disposable production technology. Developments in this field are continuously integrated into Redbiotec’s rePAX® platform.